assumes a minimum of 12 months of treatment. A more specific statement is not possible because of the lack of PMR studies on this particular topic and because of the multiple subgroups and factors that need to be taken into account. Recommendation 3: (PICOs 3-5) The panel conditionally recommends using the minimum effective GC dose within a range of 12.5-25 mg prednisone equivalent daily as the initial treatment of PMR. A higher initial prednisone dose within this range may be considered in